Novartis Investigative Site

Moriguchi, Osaka 570-8507

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Multiple Sclerosis

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling